[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@JoseRestonVA Jose HurtadoJose Hurtado posts on X about $mdgl, $rna, $orka, $rog the most. They currently have XXXXX followers and 1220 posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks cryptocurrencies finance currencies
Social topic influence $mdgl #11, $rna #5, $orka #3, $rog, $apge #4, $janx #15, $zeal #9, rog, i am, $abvx #59
Top accounts mentioned or mentioned by @monacobiotech @jfais20 @datadinvesting @amaymd @andreagtc @krossroads @sanctuarybio @pharmdca @geneinvesting @seedy19tron @wallstsai @bioinvestor24 @maximusholla @ltbioinvestor @johnbresnahan @semodough @aafree @biohazard3737 @avidresearch @saicharanaitha
Top assets mentioned Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Avidity Biosciences, Inc. Common Stock (RNA) Oruka Therapeutics, Inc. Common Stock (ORKA) ROGin AI (ROG) Apogee Therapeutics, Inc. Common Stock (APGE) Janux Therapeutics, Inc. Common Stock (JANX) IDEAYA Biosciences, Inc. Common Stock (IDYA) Immunovant, Inc. Common Stock (IMVT) uniQure N.V. (QURE) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Eli Lilly and Company (LLY) Exact Sciences Corp (EXAS) Insmed, Inc. (INSM) BridgeBio Pharma, Inc. Common Stock (BBIO) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Revolution Medicines, Inc. Common Stock (RVMD) Natera, Inc. Common Stock (NTRA) Regeneron Pharmaceuticals Inc (REGN) Biogen Inc (BIIB) Credit Suisse Group (CS) Dyne Therapeutics, Inc. Common Stock (DYN) Sarepta Therapeutics, Inc. (SRPT) The Scotts Miracle-Gro Company (SMG) Novartis AG (NVS) Itau Unibanco Holding S.A. (ITUB) NuCypher (NU) Credicorp LTD (BAP) Merus N.V. Common Shares (MRUS) Metsera, Inc. Common Stock (MTSR) Akropolis (AKRO) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Intra-Cellular Therapies Inc. (ITCI) NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
Top posts by engagements in the last XX hours
"Opened a small position of Zealand Pharma in the Danish market - $ZEAL"
X Link 2025-10-07T10:41Z 3365 followers, 4055 engagements
"@PersimmonTI I was looking at YTD returns among BP and as great as $LLY is $RHHBY has outperformed it (I own $ROG returns are lower because they are in CHF but then CHF appreciated vs. the USD) with room to grow if obesity hits"
X Link 2025-11-23T21:28Z 3365 followers, XXX engagements
"Wrong take. A simple look at the main components of the ETF tells the real story behind it. Just as example looking at the top XX names shown in StareStreet site: - $EXAS and $RNA (bought out) - $INSM $MDGL $BBIO $IONS - commercial stage bios with potential blockbuster products - $RVMD $NTRA - high quality bios - $REGN (see Dupixent revenues) $BIIB (large commercial) The list goes on. Yes at the end of the list you can find lower-quality bios that could potentially benefit from the ETF but the sector has produced true outperformersand investors have benefited by looking under the ETF"
X Link 2025-11-28T21:09Z 3365 followers, XXX engagements
"That is a plausible hypothesis. Data that gets released next year may or may not confirm. The good thing about $ROG -which I hold before it started headed in the obesity path - is that other areas / assets are showing encouraging results so I have optionality elsewhere in case this goes in the wrong direction (still tbd). Among my defensive names this year has been one of my outperformers"
X Link 2025-12-01T13:09Z 3365 followers, XXX engagements
"@monaco_biotech Sold $JANX at loss. This leadership team inspires no confidence. Not willing to wait"
X Link 2025-12-01T22:36Z 3365 followers, 3183 engagements
"Rebought $JANX at $XXXXX for a trade"
X Link 2025-12-02T14:36Z 3365 followers, 4154 engagements
"Zrich this evening. That building with the red lightsthat was Credit Suisse"
X Link 2025-12-05T19:27Z 3365 followers, 2694 engagements
"@bioinvestor24 Different exons. $RNA has Exon-44. $DYN trial seems it is targeting Exon-51. That goes to $SRPT to care about it not Vas"
X Link 2025-12-07T21:46Z 3365 followers, XXX engagements
"In my Swiss portfolio started a small position in Swiss Marketplace Group $SMG. I plan to accumulate from time to time with a LT horizon (buying at a XX% discount from IPO good enough for me)"
X Link 2025-12-08T13:11Z 3365 followers, 2044 engagements
"@A_May_MD @Steptradez $APGE might not be a me-too. I fundamentally disagree here"
X Link 2025-12-08T22:12Z 3365 followers, 1519 engagements
"@a_a_free Now I need to look at $SYRE To think that $ORKA was here just a few months ago"
X Link 2025-12-10T20:26Z 3365 followers, XXX engagements
"Added to $ORKA $XX. No longer my smallest position (still very small). Will continue doing this from time to time. No rush"
X Link 2025-09-17T16:44Z 3358 followers, 2277 engagements
"@monaco_biotech In line with what I am seeing this morning with the trajectory of my Swiss names like Novartis $NOVN Roche $ROG Lonza $LONN . So far irrelevance"
X Link 2025-09-26T10:21Z 3363 followers, 2245 engagements
"Added to $ORKA"
X Link 2025-11-04T20:36Z 3358 followers, 3031 engagements
"@jfais20 Oh no.absolutely not. That is why I have been taking profits and planning to be very careful when I put idle funds back to work in bios. I am in the camp that we need a breather. So yes Swisscom and others are attractive to me these days :)"
X Link 2025-11-27T14:19Z 3360 followers, XXX engagements
"@Biotech2k1 Itau is a great bank. Compared to $NU $ITUB it is orders of magnitude cheaper"
X Link 2025-12-08T15:45Z 3363 followers, XXX engagements
"@Biotech2k1 $BAP - Credicorp the largest Peruvian conglomerate. All I will say is (1) I am familiar with it (2) it is as solid as it can be"
X Link 2025-12-08T17:12Z 3363 followers, XXX engagements
"Updated biotech portfolio after acquisitions additions adjustments and price fluctuations: Top 5: $MDGL $RNA $APGE $ABVX $IDYA Sizable positions: $IMVT $ORKA $ZEAL(Danish market) Others: $QURE $CTMX $OVID $NKTR $BHVN $JANX $ORIC $CRVS I have other positions in the Swiss market some partial hedges and options . Increased cash levels"
X Link 2025-10-13T06:22Z 3364 followers, 23.8K engagements
"@jfais20 No5 so far: $RNA $MRUS $MTSR $AKRO and $SWTX (in that order). I was able to extract a few % bps on $ITCI between the article and final announcement but that was not a b/o for me. That streak cannot repeat 😬"
X Link 2025-11-24T15:55Z 3364 followers, 1338 engagements
"We all have our bad ones. Current underperformers: $BHVN $QURE $IMVT. Worst stock YTD I hold is not a bio but an industrial in my Swiss portfolio: $SIKA. But when looking at the totality of good ones vs bad onesthis is still my best year. Even holding cash in CHF outperformed versus the USD"
X Link 2025-11-24T18:56Z 3364 followers, 1659 engagements
"Exited my top position $RNA (changed my mind and opted to cash out) and reduced my 2nd one $MDGL by an additional XX% in shares near $XXX. It is back to my top position but at a XX% shares from original. Choosing to take profits raise cash and wait for opportunities. What a ride"
X Link 2025-11-25T15:34Z 3364 followers, 7440 engagements
"Now top X bios after exits and trimming: $MDGL $APGE $ABVX $IDYA and $ORKA Right next: $ZEAL $NAMS"
X Link 2025-11-25T17:27Z 3364 followers, 7714 engagements
"It depends. You realize that etruxifermin (I was long AKRO when acquired by NVO) has competition by Resmetirom ( $MDGL - long top position) that is X years ahead and pegozafermin now under Roche (also long via $ROG) Time to market is also a factor assuming that they are all successful"
X Link 2025-11-27T18:56Z 3364 followers, 1215 engagements
"@BiotechSho99376 After your $MDGL comment here the stock went up 2x. Noticing similar types of calls on other names"
X Link 2025-11-28T14:07Z 3364 followers, 1412 engagements
"@zohmbastic Interesting behavior with $APGE"
X Link 2025-12-03T18:17Z 3364 followers, XXX engagements
"Galderma $GALD in the Swiss market - not only about Nemluvio launch. Stellar performance since April 25"
X Link 2025-12-08T09:26Z 3364 followers, 2538 engagements
"@_le_Lounge Still early. No catalysts nearby. That said the current valuation today considering that they have a Phase-3 ready asset.and a Phase-2 of the same asset in another indication to start. I will continue adding to $LBRX from time to time. No rush"
X Link 2025-12-08T21:59Z 3364 followers, XXX engagements
"@LTbioinvestor @jfais20 Thank you You know how this iswith its ups and downs. Just trying to finish the year the way I would like to finish"
X Link 2025-12-11T14:26Z 3364 followers, XXX engagements